The size of the European dermal fillers market is expected to grow at a compound annual growth rate of 6.7% over the forecast period, reaching approximately USD 1669 million by 2029 from 1207 million in 2024.
The increasing concern of many people regarding aging symptoms is propelling the growth of the European dermal fillers market. Aging symptoms such as wrinkles, sagging skin, and scars are the primary concern for many people, especially females. Using dermal fillers helps reduce these problems with advanced technology procedures—the increase in the geriatric population in the region, where they complain about aging symptoms. The speed of aging among people is increasing for various social and economic reasons. The increasing healthcare infrastructure awareness among the people is enhancing the dermal fillers market in Europe. The increasing beauty concern among the people is influencing them to invest in dermal fillers in Europe by prompting market growth.
The rising prevalence of minimally invasive products is contributing to the growth of the European market. Minimally invasive procedures include specially designed instruments that act on tightening the skin, bringing back the younger look. By using minimal invasive products, there is no risk of adverse effects as these focus on the facial wrinkles and fine lines, which contour unwanted fat where there are no cuts or minimal cuts for the surgery process. The demand is high for minimally invasive energy-based treatments such as skin tightening, wrinkle reduction, face contouring, and skin rejuvenation, accelerating the European dermal fillers market growth. People are becoming more aware of aesthetic devices and procedures with the advanced technology in the healthcare system, which is enhancing market value growth.
The increasing advancements in the new dermal fillers are expected to create lucrative opportunities for market expansion over the forecast period. The availability of different dermal filler drugs is attracting most of the population, which creates possibilities in the market. The increasing technological advancements in procedures and techniques are propelling market expansion. Governments of various countries are taking the initiative, focusing on R&D of aesthetic procedures to improve techniques and achieve better results.
The high cost of aesthetic procedures is the primary factor hampering the growth of the European dermal fillers market. The cost depends on the type of treatment, the amount used in the treatment process, and the expertise of the person performing the procedure. The high cost is pulling back customers even though they are interested in the procedures. Many emerging countries' governments must provide insurance or reimbursement for aesthetic procedures, hindering the European market growth. Aesthetic procedures are special procedures that need to be done with care and experience. The presence of skilled personnel is necessary for implementing the procedure. The need for more skilled personnel due to rapid technological advancements is challenging for the market's expansion. The requirement of specific skilled personnel makes it challenging for manufacturers to increase their market value.
Impact of COVID-19 on the European dermal fillers market:
COVID-19 impacted the European derma fillers market due to the closure of hospitals and clinics. Under strict restrictions and regulations, only emergency cases were taken, and all other non-urgency cases were postponed avoiding the spread of the pandemic. As per a 2021 article published by Pharmaceutical Technology, over 81% of UK-based aesthetic businesses were forced to close during COVID-19 to reduce the health risks and overwork on healthcare systems. From 2022, the market has observed steady growth due to increased cosmetic surgeries.
This research report on the European Dermal Fillers Market has been segmented & sub-segmented into the following categories:
Europe Dermal Fillers Market - By Product:
The absorbable segment of dermal fillers dominated with a significant share of market revenue, with a share of 99% in 2023. The biodegradable fillers naturally blend with the skin tissue and give a natural look to the skin. The body's metabolic activities naturally degrade into the skin with time. The slow degradation of the drug into the skin reduces the risk of artificial changes in appearance by allowing modifications when required. Once the filler degrades in the skin, no sagging is observed. It naturally tightens the skin. These filler treatments last from 6 to 18 months.
The non-biodegradable segment is losing market value due to several disadvantages, such as the lack of a reverse process after the fillers.
Europe Dermal Fillers Market - By Therapeutic Area:
The wrinkles segment had the largest share in the European dermal fillers market revenue due to its typical appearance on the skin with aging. Wrinkles are the most common complaint observed in most of the population. People are aware of the product's effectiveness in facial line correction treatment. The availability of the existing products is enhancing the growth of the market size.
Scar treatment and other treatments are anticipated to grow during the forecast period. These products offer collagen-boosting properties, which accelerate the market value.
Europe Dermal Fillers Market - By Country:
The European region had a substantial share of the global market in 2023. The rising attraction of consumers towards beauty and wellness, increasing healthcare expenditure, availability of various types of dermal fillers for different parts of the body, and increasing drug approvals are driving the dermal fillers market in this region. In addition, increasing at-home service for dermal filler treatment in this region results in more people adopting this treatment for skin issues. Furthermore, increasing social media popularity in the usage of dermal fillers fuels the demand for dermal fillers in Europe. Most young people are taking this dermal filler treatment to look good on Facebook, Twitter, and other social media platforms. Most dermal filler companies keep advertisements of the usage of dermal fillers and the results after the treatment to increase awareness and the adoption rate among people.
Germany and the UK accounted for a significant European market share in 2023. The increasing problem of wrinkles in most people in Germany is propelling the market growth. Increasing dermal filler-related clinics in recent years in this region due to the increasing adoption of a large number of people is also a factor for market growth. An increasing number of specialists in this treatment and a reduction in treatment costs also help the market grow. Increasing advancements in this derma filler treatment boost the market in the United Kingdom. These filler treatments are not permanent, lasting from six to 18 months. Many key players are focusing on developing advanced dermal filler treatments with advanced technology to reduce pain and increase the life of the treatment from one year to two years. In the UK, lip filler and jawline alternations are the most taken treatments by the UK people.
KEY MARKET PLAYERS:
Companies playing a significant role in the Europe dermal fillers market profiled in this report are Allergan Inc., AQTIS Medical, Bioha Laboratories, Suneva Medical, Galderma, Merz Aesthetics, Cynosure, Syneron, and Cytophil Inc.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region